Lifevantage Stock Plunges 16.94% on Earnings Miss

On September 5, 2025, Lifevantage's stock experienced a significant drop of 16.94% in pre-market trading, reflecting investor concerns over the company's recent financial performance.

Lifevantage reported fourth-quarter revenue of $55.1 million, marking a 12.6% year-over-year increase. However, this figure fell short of analyst expectations, which had projected $56.88 million. The company's adjusted earnings per share also came in below estimates, contributing to the stock's decline.

During the earnings call, Lifevantage's management attributed the revenue shortfall to various factors, including market conditions and operational challenges. Despite the miss, the company highlighted positive aspects such as a 79.9% gross margin and growth in key product lines like MindBody GLP-1, as well as international expansion efforts.

Looking ahead, Lifevantage has outlined a fiscal year 2026 revenue target ranging from $225 million to $240 million, which is slightly below the analyst consensus of $231.3 million. This guidance suggests a cautious outlook, which may continue to weigh on the stock in the near term.